These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 36376043)

  • 1. Psilocybin mushrooms for psychological and existential distress: Treatment for a patient with palliative lung cancer.
    Patchett-Marble R; O'Sullivan S; Tadwalkar S; Hapke E
    Can Fam Physician; 2022 Nov; 68(11):823-827. PubMed ID: 36376043
    [No Abstract]   [Full Text] [Related]  

  • 2. Exploring the Use of Psilocybin Therapy for Existential Distress: A Qualitative Study of Palliative Care Provider Perceptions.
    Mayer CE; LeBaron VT; Acquaviva KD
    J Psychoactive Drugs; 2022; 54(1):81-92. PubMed ID: 34266372
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preliminary psychometrics of the Existential Distress Scale in patients with advanced cancer.
    Lo C; Panday T; Zeppieri J; Rydall A; Murphy-Kane P; Zimmermann C; Rodin G
    Eur J Cancer Care (Engl); 2017 Nov; 26(6):. PubMed ID: 27778415
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Denver votes to decriminalise psilocybin mushrooms.
    Webster P
    Lancet; 2019 May; 393(10185):2023. PubMed ID: 31106737
    [No Abstract]   [Full Text] [Related]  

  • 5. Refractory psycho-existential distress and continuous deep sedation until death in palliative care: The French perspective.
    Reich M; Bondenet X; Rambaud L; Ait-Kaci F; Sedda AL; Da Silva A; Villet S; Gamblin V
    Palliat Support Care; 2020 Aug; 18(4):486-494. PubMed ID: 31551106
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comment and Response: (Lugo-Radillo & Cortez-Lopez, 2020) Long-Term Amelioration of OCD Symptoms in a Patient with Chronic Consumption of Psilocybin-Containing Mushrooms.
    Fitzpatrick CM; Anderson BT; Agin-Liebes G; Guydish J
    J Psychoactive Drugs; 2022; 54(4):324-327. PubMed ID: 35083957
    [No Abstract]   [Full Text] [Related]  

  • 7. DARK Classics in Chemical Neuroscience: Psilocybin.
    Geiger HA; Wurst MG; Daniels RN
    ACS Chem Neurosci; 2018 Oct; 9(10):2438-2447. PubMed ID: 29956917
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Healthcare professionals' perceptions of existential distress in patients with advanced cancer.
    Mok E; Lau KP; Lam WM; Chan LN; Ng JS; Chan KS
    J Adv Nurs; 2010 Jul; 66(7):1510-22. PubMed ID: 20492015
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Psilocybin Conspectus: Status, Production Methods, and Considerations.
    Plotnik L; Gibbs G; Graham T
    Int J Med Mushrooms; 2022; 24(1):1-11. PubMed ID: 35442591
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term Amelioration of OCD Symptoms in a Patient with Chronic Consumption of Psilocybin-containing Mushrooms.
    Lugo-Radillo A; Cortes-Lopez JL
    J Psychoactive Drugs; 2021; 53(2):146-148. PubMed ID: 33225874
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Physicians' experiences and perspectives regarding the use of continuous sedation until death for cancer patients in the context of psychological and existential suffering at the end of life.
    Anquinet L; Rietjens J; van der Heide A; Bruinsma S; Janssens R; Deliens L; Addington-Hall J; Smithson WH; Seymour J
    Psychooncology; 2014 May; 23(5):539-46. PubMed ID: 24307235
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Receiving palliative treatment moderates the effect of age and gender on demoralization in patients with cancer.
    Vehling S; Oechsle K; Koch U; Mehnert A
    PLoS One; 2013; 8(3):e59417. PubMed ID: 23555030
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Changes in self-reported distress in end-of-life pediatric cancer patients and their parents using the pediatric distress thermometer.
    Patel SK; Fernandez N; Wong AL; Mullins W; Turk A; Dekel N; Smith M; Ferrell B
    Psychooncology; 2014 May; 23(5):592-6. PubMed ID: 24375665
    [No Abstract]   [Full Text] [Related]  

  • 14. Is advanced cancer associated with demoralization and lower global meaning? The role of tumor stage and physical problems in explaining existential distress in cancer patients.
    Vehling S; Lehmann C; Oechsle K; Bokemeyer C; Krüll A; Koch U; Mehnert A
    Psychooncology; 2012 Jan; 21(1):54-63. PubMed ID: 21061407
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Symptom burden, loss of dignity, and demoralization in patients with cancer: a mediation model.
    Vehling S; Mehnert A
    Psychooncology; 2014 Mar; 23(3):283-90. PubMed ID: 24123321
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Psychedelics for psychological and existential distress in palliative and cancer care.
    Rosenbaum D; Boyle AB; Rosenblum AM; Ziai S; Chasen MR; Med MP
    Curr Oncol; 2019 Aug; 26(4):225-226. PubMed ID: 31548800
    [No Abstract]   [Full Text] [Related]  

  • 17. How specialist palliative care nurses identify patients with existential distress and manage their needs.
    Fay Z; OBoyle C
    Int J Palliat Nurs; 2019 May; 25(5):233-243. PubMed ID: 31116658
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of the CASH assessment tool to address existential concerns in patients with serious illness.
    Alesi ER; Ford TR; Chen CJ; Fletcher DS; Morel TD; Bobb BT; Lyckholm LJ
    J Palliat Med; 2015 Jan; 18(1):71-5. PubMed ID: 25072173
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Existential distress in cancer: Alleviating suffering from fundamental loss and change.
    Vehling S; Kissane DW
    Psychooncology; 2018 Nov; 27(11):2525-2530. PubMed ID: 30307088
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The caregiver's perspective on existential and spiritual distress in palliative care.
    Boston PH; Mount BM
    J Pain Symptom Manage; 2006 Jul; 32(1):13-26. PubMed ID: 16824981
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.